InvestorsHub Logo

north40000

08/31/16 10:32 AM

#95081 RE: senderos #95080

The off-label prescriptions for indications other than the one specific FDA-approved indication are themselves significant. My DES disappeared within days of initiating Vascepa use in April 2013. Amarin is one of our largest holdings...overall basis in 3 portfolios is ~ $2.30.

Note other links in my profile above under "My Stocks" which will give you an idea of potential and actual promotion and marketing power Amarin has under the 1st Amendment.